Cargando…
Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module
BACKGROUND: Health-related quality of life (HRQoL) is an important outcome to assess the impact of cancer. This article examines the psychometric properties of the European Portuguese self-report version of the Pediatric Quality of Life Inventory™ Cancer Module (PedsQL™ 3.0 Cancer Module) in childre...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752803/ https://www.ncbi.nlm.nih.gov/pubmed/26872726 http://dx.doi.org/10.1186/s12955-016-0421-y |
_version_ | 1782415794545623040 |
---|---|
author | Santos, Susana Crespo, Carla Canavarro, M. Cristina Fernandes, Ananda Batalha, Luís de Campos, Diana Pinto, Armando |
author_facet | Santos, Susana Crespo, Carla Canavarro, M. Cristina Fernandes, Ananda Batalha, Luís de Campos, Diana Pinto, Armando |
author_sort | Santos, Susana |
collection | PubMed |
description | BACKGROUND: Health-related quality of life (HRQoL) is an important outcome to assess the impact of cancer. This article examines the psychometric properties of the European Portuguese self-report version of the Pediatric Quality of Life Inventory™ Cancer Module (PedsQL™ 3.0 Cancer Module) in children and adolescents with cancer. METHODS: The participants, 332 children/adolescents diagnosed with cancer (8–18 years old), completed measures to assess HRQoL (PedsQL™ 3.0 Cancer Module and DISABKIDS Chronic Generic Measure; DCGM-12) and anxiety (Revised Children’s Manifest Anxiety Scale - second edition; RCMAS-2). A subsample (n = 52) completed the PedsQL™ 3.0 Cancer Module a second time following one-week. The pediatric oncologists completed the Intensity of Treatment Rating Scale 3.0 (ITR 3.0). RESULTS: For the whole sample, the PedsQL™ 3.0 Cancer Module demonstrated good item discrimination (rs = .30 to .54). The confirmatory factor analysis testing the presence of eight first-order factors loading significantly in a second-order factor revealed an acceptable fit (CFI = .91; RMSEA = .05). The correlation of PedsQL™ 3.0 Cancer Module with DCGM-12 (rs = .17 to .58), and with RCMAS-2 (rs = −.16 to–.51) attested convergent validity. This inventory demonstrated minimally acceptable to very good internal consistency (αs = .65 to .87) and temporal stability (ICCs = .61 to .81). CONCLUSIONS: These findings demonstrate that the European Portuguese self-report version of the PedsQL™ 3.0 Cancer Module is a valid and reliable instrument for assessing HRQoL in pediatric cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-016-0421-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4752803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47528032016-02-14 Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module Santos, Susana Crespo, Carla Canavarro, M. Cristina Fernandes, Ananda Batalha, Luís de Campos, Diana Pinto, Armando Health Qual Life Outcomes Research BACKGROUND: Health-related quality of life (HRQoL) is an important outcome to assess the impact of cancer. This article examines the psychometric properties of the European Portuguese self-report version of the Pediatric Quality of Life Inventory™ Cancer Module (PedsQL™ 3.0 Cancer Module) in children and adolescents with cancer. METHODS: The participants, 332 children/adolescents diagnosed with cancer (8–18 years old), completed measures to assess HRQoL (PedsQL™ 3.0 Cancer Module and DISABKIDS Chronic Generic Measure; DCGM-12) and anxiety (Revised Children’s Manifest Anxiety Scale - second edition; RCMAS-2). A subsample (n = 52) completed the PedsQL™ 3.0 Cancer Module a second time following one-week. The pediatric oncologists completed the Intensity of Treatment Rating Scale 3.0 (ITR 3.0). RESULTS: For the whole sample, the PedsQL™ 3.0 Cancer Module demonstrated good item discrimination (rs = .30 to .54). The confirmatory factor analysis testing the presence of eight first-order factors loading significantly in a second-order factor revealed an acceptable fit (CFI = .91; RMSEA = .05). The correlation of PedsQL™ 3.0 Cancer Module with DCGM-12 (rs = .17 to .58), and with RCMAS-2 (rs = −.16 to–.51) attested convergent validity. This inventory demonstrated minimally acceptable to very good internal consistency (αs = .65 to .87) and temporal stability (ICCs = .61 to .81). CONCLUSIONS: These findings demonstrate that the European Portuguese self-report version of the PedsQL™ 3.0 Cancer Module is a valid and reliable instrument for assessing HRQoL in pediatric cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-016-0421-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-13 /pmc/articles/PMC4752803/ /pubmed/26872726 http://dx.doi.org/10.1186/s12955-016-0421-y Text en © Santos et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Santos, Susana Crespo, Carla Canavarro, M. Cristina Fernandes, Ananda Batalha, Luís de Campos, Diana Pinto, Armando Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module |
title | Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module |
title_full | Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module |
title_fullStr | Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module |
title_full_unstemmed | Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module |
title_short | Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module |
title_sort | psychometric study of the european portuguese version of the pedsql 3.0 cancer module |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752803/ https://www.ncbi.nlm.nih.gov/pubmed/26872726 http://dx.doi.org/10.1186/s12955-016-0421-y |
work_keys_str_mv | AT santossusana psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule AT crespocarla psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule AT canavarromcristina psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule AT fernandesananda psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule AT batalhaluis psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule AT decamposdiana psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule AT pintoarmando psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule |